Scott Ostriker

Scott Ostriker has extensive experience in the healthcare and pharmaceutical industry, spanning over 25 years. Scott is currently working as a Senior Medical Science Liaison in Oncology at Stemline Therapeutics. Prior to this, they held the position of Field Medical Director in ImmunoDermatology at Dermavant Sciences. Before that, they worked as a Principal Medical Science Liaison in Oncology at Nektar Therapeutics.

From 2018 to 2022, Scott worked at Daiichi Sankyo, Inc., where they held various roles, including Senior Health Outcomes Liaison in Hematology/Oncology, Senior Medical Science Liaison in Oncology, and Medical Science Liaison in Oncology/Hematology.

Scott started their career in 1996 at the U.S. Department of Veterans Affairs as a Pharmacy Intern/Staff Pharmacist. Scott then moved on to work in different healthcare institutions such as Duke University Health System, University of Washington Medical Center, Cascade Cancer Center, Dana-Farber Cancer Institute, and UMass Memorial Health, where they served in various roles related to clinical pharmacy and management.

Throughout their career, Scott has gained a wealth of experience in oncology and hematology, demonstrating their expertise in medical science liaison, pharmacy management, clinical pharmacy, and patient care.

Scott Ostriker completed their education with a Master of Business Administration (MBA) degree in Healthcare from The George Washington University School of Business between 2007 and 2009. Prior to that, they earned a Doctor of Pharmacy (PharmD) degree in Pharmacy from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences from 1997 to 1999. Scott also obtained a Bachelor of Science degree in Pharmacy from the same institution between 1995 and 1998. In 1992, Scott Ostriker attended the University of Washington, but it is unclear if they obtained a degree from there. In terms of certifications, they are a Lean Six Sigma Black Belt (LSSBB) acquired from UMass Memorial Health in June 2015, and they also hold the certification of a Board Certified Oncology Pharmacist (BCOP) which they obtained from BPS - Board of Pharmacy Specialties in December 2002.